Probiotic bacteria that evolves with us

From the same bacteria found in yogurt, we use a genetically modified probiotic bacteria to safely and selectively deliver genetical material to tissues in the body.

Living Bio-factories


Symvivo has invented and patented a novel protein based mechanism that enables the bacteria to consistently produce and deliver therapeutic plasmid DNA to colonized tissues.

Extending to new opportunities

Through oral ingestion or intravenous infusion, we can use this platform for many therapeutic applications including: oncology, cardiovascular injuries, infectious diseases, vaccines, and genetic diseases.

Get in touch

get in touch

Contact us if you're interested in partnering or collaborating.